There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Related collections

Data availability:

ScienceOpen disciplines: Medicine, Rheumatology

Comments

Comment on this article

Cited by 1

Efficacy and safety of tofacitinib as monotherapy in Japanese patients with active rheumatoid arthritis: a 12-week, randomized, phase 2 study
Authors: Yoshiya Tanaka, Tsutomu Takeuchi, Hisashi Yamanaka …

See all cited by

Tofacitinib (CP-690,550), an oral JAK inhibitor, in combination with traditional DMARDS: Phase 3 study in patients with active rheumatoid arthritis with inadequate response to DMARDs

Read this article at

Related collections

Active Travel Studies

Comments

Comment on this article

Similar content 1,382

Cited by 1